Saturday, December 20, 2014 4:51:05 PM
rube PR release just two weeks ago...
"...and will be available before the end of 2014 for Investigational Use Only to assist the biopharmaceutical industry in its therapeutic Alzheimer's development programs."
GC et al will be PUNISHED if they dont launch next week or the week thereafter...if they do launch next week, the trading is typically thin, so pps climb could be breath-taking....
why convert E series at 8c instead of LPC? (because lpc will purchase shares upto 50c)
5M from E series dilution so far is only HALF of what the cost is correct?? thus...they must be planning on funds coming from elsewhere...so my thought is...they might have the half already secured via partnership spinoff of lympro upfront payment or pre-existing sales since the ESS-w closing date is Jan 31st.
comments/rebuttals warmly welcomed AMBS community.
Avant Technologies Engages Wired4Tech to Evaluate the Performance of Next Generation AI Server Technology • AVAI • May 23, 2024 8:00 AM
Branded Legacy, Inc. Unveils Collaboration with Celebrity Tattoo Artist Kat Tat for New Tattoo Aftercare Product • BLEG • May 22, 2024 8:30 AM
"Defo's Morning Briefing" Set to Debut for "GreenliteTV" • GRNL • May 21, 2024 2:28 PM
North Bay Resources Announces 50/50 JV at Fran Gold Project, British Columbia; Initiates NI 43-101 Resources Estimate and Bulk Sample • NBRI • May 21, 2024 9:07 AM
Greenlite Ventures Inks Deal to Acquire No Limit Technology • GRNL • May 17, 2024 3:00 PM
Music Licensing, Inc. (OTC: SONG) Subsidiary Pro Music Rights Secures Final Judgment of $114,081.30 USD, Demonstrating Strength of Licensing Agreements • SONGD • May 17, 2024 11:00 AM